Ray Sumita 4

4 · Cue Biopharma, Inc. · Filed Jul 10, 2026

AI-generated summary of this filing

Updated Jul 10, 2026

Cue Biopharma (CUE) Chief Legal Officer Ray Sumita Receives Award

What Happened

Ray Sumita, Chief Legal Compliance Officer and Corporate Secretary of Cue Biopharma (CUE), received equity awards on 2026-07-09: 54,589 restricted stock units (RSUs) and 54,589 performance stock units (PSUs). Both awards were recorded at $0.00 per share (typical for compensation grants). Total units granted = 109,178.

Key Details

Transaction date: 2026-07-09; Form 4 filed 2026-07-10 (timely).
Grant type(s): A = Award/Grant. One grant reported as RSUs (non-derivative); the other reported as PSUs (derivative/security-based on performance).
Price: $0.00 per unit; aggregate cash value shown as $0 on the filing.
Vesting:
- RSUs: vest in equal quarterly installments over 48 months from grant date, subject to continued service. (Footnote F1)
- PSUs: three substantially equal tranches tied to stock-price targets ($33.00, $38.50, $44.00) that require a closing price for five consecutive trading days; if targets aren’t met within 24 months, the PSUs are forfeited. (Footnote F2)
Shares owned after the transaction: not specified in this filing.
Filing timeliness: filed within the required Form 4 window (not marked late).

Context

These awards are compensation grants (not open-market purchases or sales) and are common for executives; they do not represent an immediate cash investment or sale. PSUs are contingent/derivative awards that only convert to shares if performance targets are met; RSUs vest over time with continued service.

Form 4

Period: 2026-07-09

Chief Legal Compliance OfficerOther

Transactions

Award
Common Stock
[F1]
2026-07-09+54,589→ 109,178 total
Award
Common Stock
[F2]
2026-07-09+54,589→ 54,589 total
→ Common Stock (54,589 underlying)

Footnotes (2)

[F1]Represents that grant of restricted stock units ("RSUs"). The shares subject to the RSUs vest in equal quarterly installments over a period of forty-eight (48) months, measured from the date of grant, subject to the reporting person's continued service with the issuer through each vest date.
[F2]Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

Signature

/s/ Sumita Ray|2026-07-10

1 file